RADIOPHARMACEUTICAL IMAGING DETECTION

Brand Owner Address Description
TUMORVUE Molecular Targeting Technologies, Inc. 833 Lincoln Ave., Unit 9 West Chester PA 19380 Radiopharmaceutical and imaging and detection agent for diagnosing and monitoring diseases, namely, noninvasive agent for whole body targeting of treatment response for clinical applications for cancer and cardiovascular diseases;TUMOR VIEW;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A novel method is set out of preparation of radioactive diagnostic radiopharmaceutical in a stable, shippable, lyophilized form by an apparatus designed to rapidly flash freeze and dehydrate a radiopharmaceutical composition to minimize auto radiolysis. The method proposes rapid cooling and removal of ambient vapor, and then ultra cold removal when the potential of explosive liquid oxygen is eliminated. The radioactive diagnostic radiopharmaceutical requires no further cold or refrigerated storage, including with respect to shipping, subsequent to stabilization. The preferred composition can be reconstituted "on site" by the addition of a suitable diluent to bring the radiopharmaceutical complex into solution at a desired concentration.